DLTR:NASDAQDollar Tree, Inc. Analysis
Data as of 2026-03-10 - not real-time
$116.82
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Dollar Tree is trading below its short‑term moving averages, with the price sitting under both the 20‑day and 50‑day SMAs, suggesting a modestly bearish technical backdrop. The RSI is in the lower half of its range, indicating limited momentum to the upside, while the MACD line remains under its signal line, reinforcing a bearish signal. Volume has been on a decreasing trend, which can signal waning short‑term buying interest. Despite these technical headwinds, the stock’s beta is modest, reflecting lower sensitivity to broader market swings, but the 30‑day volatility is elevated, pointing to sizable price swings. A discounted cash flow model places fair value well above the current market price, implying an upside potential in the mid‑single digits. However, the company reports a negative profit margin and carries a very high debt‑to‑equity ratio, which raises concerns about earnings sustainability.
The analyst consensus is neutral, with a “hold” recommendation and recent coverage has been downgraded by BMO Capital, adding a negative sentiment overlay. The defensive consumer sector footing provides a cushion against economic downturns, and revenue growth remains positive, offering a modest growth narrative. The lack of a dividend eliminates any income component, and the high leverage may limit financial flexibility. Overall, the valuation appears attractive relative to intrinsic estimates, but execution risks tied to profitability and leverage remain pivotal. Investors should weigh the short‑term technical softness against the longer‑term undervaluation and sector resilience.
The analyst consensus is neutral, with a “hold” recommendation and recent coverage has been downgraded by BMO Capital, adding a negative sentiment overlay. The defensive consumer sector footing provides a cushion against economic downturns, and revenue growth remains positive, offering a modest growth narrative. The lack of a dividend eliminates any income component, and the high leverage may limit financial flexibility. Overall, the valuation appears attractive relative to intrinsic estimates, but execution risks tied to profitability and leverage remain pivotal. Investors should weigh the short‑term technical softness against the longer‑term undervaluation and sector resilience.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price below short‑term moving averages
- bearish MACD and decreasing volume
- recent analyst downgrade
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value above market price
- steady revenue growth in a defensive sector
- potential for margin improvement
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- defensive consumer positioning
- undervalued relative to intrinsic estimate
- capacity to reduce leverage over time
Key Metrics & Analysis
Financial Health
Revenue Growth9.40%
Profit Margin-15.40%
P/E Ratio22.1
ROE20.07%
ROA5.11%
Debt/Equity221.06
P/B Ratio6.8
Op. Cash Flow$2.7B
Free Cash Flow$1.7B
Technical Analysis
TrendNeutral
RSI37.3
Support$111.30
Resistance$138.91
MA 20$124.72
MA 50$126.40
MA 200$110.00
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$133.45
Target Price$126.30
Upside/Downside8.12%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.59
Volatility32.88%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.